Open-market BuyHigh signal 70/100
filed 2026-10-05OIInsider
Opaleye Management Inc. - 10% Owner - $79.0K
Open-market purchases use the insider's own money, so they are generally more informative than awards or option mechanics.
View source filingG
SEC EDGAR - Form 4 insider activity
Grace Therapeutics, Inc. $GRCE
Tracked equity - 3 filings indexed by Nortis
Nortis signal thesis
Buying activity is leading recent insider flow.
3
OM buys - 90d
0
OM sells - 90d
0
Routine filings
0
Cluster filings
$79.0K
Largest trade
70/100
Avg signal score
Filing tape
Recent filings
Open-market BuyHigh signal 70/100
filed 2026-10-01OIInsider
Opaleye Management Inc. - 10% Owner - $16.4K
Open-market purchases use the insider's own money, so they are generally more informative than awards or option mechanics.
View source filingOpen-market BuyHigh signal 70/100
filed 2026-10-01OIInsider
Opaleye Management Inc. - 10% Owner - $20.5K
Open-market purchases use the insider's own money, so they are generally more informative than awards or option mechanics.
View source filing